Skip to main content

Therapeutic Vaccines Market is Estimated to Witness High Growth

Therapeutic Vaccines Market

Therapeutic vaccines are immunotherapies intended to prevent or treat chronic diseases by stimulating the body's immune system. These vaccines utilize disease-related proteins or peptides to trigger an immune response against cancers, chronic viral infections, allergies, and others, offering targeted treatment with fewer side effects than conventional therapies. The growing incidence of chronic illnesses and limitations of existing treatment modalities have led to an increased focus on developing therapeutic vaccines. The global therapeutic vaccines market is estimated to be valued at US$ 3.09 billion in 2024 and is expected to exhibit a CAGR of 3.5% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The growing prevalence of chronic diseases represents a major market opportunity for therapeutic vaccines. Chronic conditions such as cancers, HIV/AIDS, diabetes, and autoimmune disorders have emerged as leading causes of mortality and morbidity worldwide. However, current treatment approaches often face limitations in terms of effectiveness, safety, and cost of care. Therapeutic vaccines offer the promise of enhanced therapeutic outcomes by specifically targeting disease-causing agents with reduced toxicity. This addresses a major unmet need for developing more targeted and safer treatments for chronic illnesses, thus driving the demand for therapeutic vaccines globally. Moreover, rapid advancements in vaccine development technologies are enabling creation of innovative targeted immunotherapies with better efficacy and safety profiles.

Porter's Analysis

Threat of new entrants: Low, as large capital requirements and presence of established players make market entry difficult.

Bargaining power of buyers: Moderate to high as buyers have several product options available.

Bargaining power of suppliers: Moderate as key raw materials are commoditized.

Threat of new substitutes: Low as therapeutic vaccines have niche applications currently with limited substitutes.

Competitive rivalry: High among existing players to commercialize new vaccines.

SWOT Analysis

Strengths: Growing infectious disease burden boosting demand. Several vaccines in clinical trials.

Weaknesses: High R&D costs. Stringent regulatory approvals. Manufacturing complexities.

Opportunities: Emerging markets growth. Collaborations for new product development.

Threats: Patent expiries increases competition. Delays in product approval affect revenues and valuation.

Key Takeaways

The Global Therapeutic Vaccines Market Growth is expected to witness high over the forecast period of 2024-2031. The market size for 2024 is estimated at US$ 3.09 billion. North America currently dominates the market owing to presence of major players and high healthcare expenditure. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period attributed to rising geriatric population, increasing disposable incomes and growing awareness.

Regional analysis indicates that North America will continue to dominate the therapeutic vaccines market share through 2031. The presence of major market players in the US fuels market growth. However, Asia Pacific is poised to offer lucrative opportunities with the highest CAGR during the forecast period owing to high population density and growing penetration of healthcare facilities.

Key players operating in the therapeutic vaccines market are AMR India Limited, Carmeuse, GLC Minerals LLC, Graymont Limited, Gujarat Mineral Development Corporation Ltd, Imerys, Kerford Limestone, LafargeHolcim, Lhoist Group, Minerals Technologies Inc., Okutama Kogyo Co. Ltd, Omya AG, RSMM Limited, Ryokolime Industry Co. Ltd (Mitsubishi Materials Corporation), SCHAEFER KALK GmbH & Co. KG, The National Lime & Stone Company, and United States Lime & Minerals Inc. These companies are focused on expanding their product portfolios through acquisitions and collaborations for commercializing new vaccines.

Explore more information on this topic, Please visit -

https://www.ukwebwire.com/therapeutic-vaccines-market-growth-and-outlook-analysis/ 

Explore more trending article related this topic -

https://www.insightprobing.com/biopharma-buffer-market-share-and-demand-analysis/ 

Labels:

Comments

Post a Comment

Popular posts from this blog

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...
Post a Comment
Read more

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...
Post a Comment
Read more

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...
Post a Comment
Read more